BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36326583)

  • 1. Societal costs of ovarian cancer in a population-based cohort - a cost of illness analysis.
    Palmqvist C; Persson J; Albertsson P; Dahm-Kähler P; Johansson M
    Acta Oncol; 2022 Nov; 61(11):1369-1376. PubMed ID: 36326583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study.
    Delgado-Ortega L; González-Domínguez A; Borrás JM; Oliva-Moreno J; González-Haba E; Menjón S; Pérez P; Vicente D; Cordero L; Jiménez M; Simón S; Hidalgo-Vega Á; Moya-Alarcón C
    Eur J Health Econ; 2019 Feb; 20(1):135-147. PubMed ID: 29922900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of rheumatoid arthritis from a societal perspective: A prevalence-based study on cost of this illness for patients in China.
    Hu H; Luan L; Yang K; Li SC
    Int J Rheum Dis; 2018 Aug; 21(8):1572-1580. PubMed ID: 28211251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer.
    Simmons D; Blank SV; ElNaggar AC; Chastek B; Bunner SH; McLaurin K
    Adv Ther; 2022 Jun; 39(6):2544-2561. PubMed ID: 35362863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
    Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
    Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of Care for the Initial Management of Ovarian Cancer.
    Bercow AS; Chen L; Chatterjee S; Tergas AI; Hou JY; Burke WM; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Obstet Gynecol; 2017 Dec; 130(6):1269-1275. PubMed ID: 29112648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The societal cost of bipolar disorder in Sweden.
    Ekman M; Granström O; Omérov S; Jacob J; Landén M
    Soc Psychiatry Psychiatr Epidemiol; 2013 Oct; 48(10):1601-10. PubMed ID: 23754681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of ulcerative colitis from a societal perspective in a regional health care area in Spain: A database study.
    Aldeguer X; Sicras-Mainar A
    Gastroenterol Hepatol; 2016 Jan; 39(1):9-19. PubMed ID: 26211705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
    Jönsen A; Hjalte F; Willim M; Carlsson KS; Sjöwall C; Svenungsson E; Leonard D; Bengtsson C; Rantapää-Dahlqvist S; Pettersson S; Gunnarsson I; Zickert A; Gustafsson JT; Rönnblom L; Petersson IF; Bengtsson AA; Nived O
    Semin Arthritis Rheum; 2016 Jun; 45(6):684-90. PubMed ID: 26743074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960-2014: A population-based cohort study.
    Leandersson P; Hogberg T; Dickman PW; Malander S; Borgfeldt C
    BMC Cancer; 2021 Apr; 21(1):465. PubMed ID: 33902507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expert panel on practice patterns in the management of cow's milk protein allergy and associated economic burden of disease on health service in Turkey.
    Sekerel BE; Seyhun O
    J Med Econ; 2017 Sep; 20(9):923-930. PubMed ID: 28602101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.
    Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J
    J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of illness of chronic kidney disease in Lebanon: from the societal and third-party payer perspectives.
    Aoun M; Helou E; Sleilaty G; Zeenny RM; Chelala D
    BMC Health Serv Res; 2022 May; 22(1):586. PubMed ID: 35501814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between health costs and physical inactivity; analysis from the Physical Activity at Work study in Thailand.
    Akksilp K; Isaranuwatchai W; Teerawattananon Y; Chen C
    Front Public Health; 2023; 11():1037699. PubMed ID: 36960361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of illness of atrial fibrillation: a nationwide study of societal impact.
    Johnsen SP; Dalby LW; Täckström T; Olsen J; Fraschke A
    BMC Health Serv Res; 2017 Nov; 17(1):714. PubMed ID: 29126415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of adverse drug events--a retrospective population-based cohort study of 4970 adults.
    Gyllensten H; Hakkarainen KM; Hägg S; Carlsten A; Petzold M; Rehnberg C; Jönsson AK
    PLoS One; 2014; 9(3):e92061. PubMed ID: 24637879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Direct and Indirect Costs of Breast Cancer in Poland: Estimates for 2017-2019.
    Seweryn M; Banas T; Augustynska J; Lorenc O; Kopel J; Pluta E; Skora T
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.